Shanghai Pulmonary Hospital, Shanghai, China: all 157 studies

Page 1 of 2. Open to participants first (94), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness and Safety of MRG003 (Becotatug Vedotin) in Relapsed SCLCRecruitingNCT07874581Not applicable
• Neoadjuvant Iruplinalkib and Bevacizumab in ALK-positive NSCLC: A Phase II Single-arm TrialNot yet recruitingNCT07870733Not applicable
• Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLCRecruitingNCT07863999Phase 3
• T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPDRecruitingNCT07823842
• Inspiratory Flow Rate Capability in Pulmonary Fibrosis PatientsRecruitingNCT07820254
• Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCRecruitingNCT07754812Phase 4
• Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.Not yet recruitingNCT07608159Phase 3
• Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II TrialNot yet recruitingNCT07599163Not applicable
• Application of Electromagnetic Navigation System in Pulmonary Nodule LocalizationNot yet recruitingNCT07595120Not applicable
• Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLCNot yet recruitingNCT07547332Phase 2
• Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II TrialNot yet recruitingNCT07517640Phase 2
• TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung SurgeryNot yet recruitingNCT07494591Not applicable
• Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer PatientsNot yet recruitingNCT07493980Phase 2
• A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based RegimensNot yet recruitingNCT07469488Phase 4
• Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung CancerRecruitingNCT07410975Phase 2
• IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerRecruitingNCT07408635Phase 2
• Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)Not yet recruitingNCT07393438Phase 2
• Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled TrialNot yet recruitingNCT07393386Phase 4
• A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational StudyNot yet recruitingNCT07375979
• Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung CancerRecruitingNCT07328945
• Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung CancerRecruitingNCT07323056Phase 2
• Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary FunctionRecruitingNCT07309393Not applicable
• Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter StudyRecruitingNCT07243873
• Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLCNot yet recruitingNCT07235306Phase 2
• Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCTNot yet recruitingNCT07169903Phase 3
• Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung CancerNot yet recruitingNCT07153770Phase 2
• Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung DiseaseNot yet recruitingNCT07141810Phase 4
• Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride BupivacaineRecruitingNCT07134660Not applicable
• Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible TuberculosisNot yet recruitingNCT07129629Phase 2
• A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingNCT07101627Phase 2
• Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033Not yet recruitingNCT07097948Phase 2
• The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe SurgeryEnrolling by invitationNCT07060625
• Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian InsufficiencyNot yet recruitingNCT07020429Not applicable
• Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer PatientsRecruitingNCT06987734Phase 2
• Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical StudyNot yet recruitingNCT06946836Phase 2
• The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and EndotypingRecruitingNCT06900062
• Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLCNot yet recruitingNCT06837948Phase 2
• A Study on the Efficacy of Atezolizumab Combined with ChemotherapyRecruitingNCT06780826
• The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk FactorsNot yet recruitingNCT06772610Phase 2
• Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)RecruitingNCT06760273
• Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung CancerRecruitingNCT06758700Phase 2
• An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line SettingRecruitingNCT06749886Phase 2
• Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expressionRecruitingNCT06749860Phase 2
• The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world StudyNot yet recruitingNCT06652555
• Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06644313Phase 2
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2
• A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung CancerNot yet recruitingNCT06620796Phase 2
• The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer PatietnsNot yet recruitingNCT06592430
• Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung CancerNot yet recruitingNCT06591910
• A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLCNot yet recruitingNCT06585644Phase 2
• Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung AdenocarcinomaRecruitingNCT06528847Phase 2
• The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC PatientsNot yet recruitingNCT06496009
• SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line TreatmentNot yet recruitingNCT06480136Phase 2
• LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT06479759Phase 2
• Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung CancerNot yet recruitingNCT06463171Phase 2
• Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLCRecruitingNCT06424821Phase 2
• Airway Clearance Technique of Oscillation and Lung Expansion in BronchiectasisRecruitingNCT06393257Not applicable
• Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary NodulesRecruitingNCT06335563Not applicable
• Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory TrialNot yet recruitingNCT06282536Phase 2
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 TrialRecruitingNCT06256237Phase 2
• Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world StudyRecruitingNCT06216782
• Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung CancerNot yet recruitingNCT06109402Phase 2
• Robot-assisted vs VATS for ThymomaRecruitingNCT06029621Not applicable
• The Efficacy and Safety of KN046 Combined With AxitinibRecruitingNCT06020352Phase 2/3
• Neoadjuvant Treatment For Locally Advanced Thymic CancerRecruitingNCT06019468Phase 2
• Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung CancerRecruitingNCT05965024
• WSI Based DL for Diagnosing the IASLC Grading System of Lung AdenocarcinomaRecruitingNCT05925764
• Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerRecruitingNCT05925751
• Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung CancerRecruitingNCT05925738
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 TrialNot yet recruitingNCT05891080Phase 2
• Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer ImmunotherapyNot yet recruitingNCT05885815
• Application of SERS Technology Based Intraoperative Navigation System in Lung CancerNot yet recruitingNCT05881057
• Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor EnvironmentRecruitingNCT05857800
• Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cmRecruitingNCT05838053
• Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung DiseaseRecruitingNCT05824988
• Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung CancerRecruitingNCT05766800Phase 2
• Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With BronchiectasisRecruitingNCT05604495
• Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung AdenocarcinomaRecruitingNCT05503667Phase 2
• The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung CancerNot yet recruitingNCT05496166Phase 3
• Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary DiseaseNot yet recruitingNCT05494957Phase 4
• A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TBRecruitingNCT05493267Phase 4
• Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical TrialRecruitingNCT05053802Phase 2
• Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cmRecruitingNCT04937283Not applicable
• Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)Not yet recruitingNCT04772287Phase 3
• Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II StudyRecruitingNCT04762030Phase 2
• Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung CancerRecruitingNCT04728724Phase 2
• Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell CarcinomaNot yet recruitingNCT04716751Phase 2
• Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural MesotheliomaNot yet recruitingNCT04713761Phase 2
• Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung CancerNot yet recruitingNCT04676815
• Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung CancerRecruitingNCT04542369Phase 2
• PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung CancerRecruitingNCT04539977Phase 2
• VATS VS. Open Thoracic Surgery for Stage II - III Lung CancerRecruitingNCT04009915Phase 3
• The Establishment of China Bronchiectasis Registry and Research CollaborationRecruitingNCT03643653
• Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%RecruitingNCT03351842Phase 2
• Assessment of an Exhaled Breath Test to Detect BronchiectasisCompletedNCT05293314Results posted
• Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.Active, not recruitingNCT07274761Phase 2
• A Retrospective Cohort Analysis of SMARCA4-Deficient Lung CancerCompletedNCT07121387
• Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung CancerWithdrawnNCT06895941
• Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung CancerCompletedNCT06648200Phase 2
• A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung CancerStatus unknownNCT06530797

← Shanghai Pulmonary Hospital, Shanghai, China overview and focus areas